IFNG and cancer: Together, these results suggested that our IFNGrGS performed better than the pan-cancer-based IFNG gene signatures in predicting the efficacy of radiotherapy and that a low IFNGrGS score implied an improved overall survival for GBM patients after radiotherapy.